ILIM
BIO icon

Irish Life Investment Managers’s Bio-Rad Laboratories Class A BIO Stock Holding History

Irish Life Investment Managers’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$98.9K Buy
+882
New +$103K ﹤0.01% 940

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Irish Life Investment Managers's BIO Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2013: 882 shares worth $98.9K. The stake represents ﹤0.01% of the portfolio and ranks #940 among its holdings.

198 funds tracked by Wall St. Rank hold BIO as of Q2 2013.

  • Irish Life Investment Managers held 882 shares of Bio-Rad Laboratories Class A worth $98.9K as of Q2 2013.
  • Bio-Rad Laboratories Class A was a new Irish Life Investment Managers position in Q2 2013.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #940 holding.
  • 198 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.